Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.
Abstract: The representation of renewable generators in dynamic simulations is growing in importance with their increasing penetration. Industry task forces have pushed for and developed generic ...